CXL-1020
CXL-1020, a proprietary compound generated by Cardioxyl's nitroxyl chemistry platform. CXL-1020 is in development for an initial indication of Acute Decompensated Heart Failure, and is currently in a Phase I/IIa clinical trial.
CXL-1020, a proprietary compound generated by Cardioxyl's nitroxyl chemistry platform. CXL-1020 is in development for an initial indication of Acute Decompensated Heart Failure, and is currently in a Phase I/IIa clinical trial.
